New Release of Cenduit’s IRT Platform and Quantum Interactive™ Updates Enable Efficient Technology Transfer and Increased Reports Customization for Clinical Trials
New capabilities designed in consultation with users delivers flawless integration, security, and ease of use for agile study build
APRIL 23 – Durham, NC – Cenduit LLC continues to drive innovation and quality as a leader in the Interactive Response Technology (IRT) marketplace, with the latest release of the Cenduit IRT platform and Quantum Interactive ™.
Cenduit CIRT combines faster study set-up times with the flexibility and benefits of customization. This enables sponsors to better meet the complexities of today’s clinical trials. Quantum Interactive™ is a configurable study design platform that expedites time to Go Live and improves study quality.
Key features of the new release include the ability to better support central pharmacies and associated sites; provide better search capability for blocking kits that may have quality issues, the ability to scan kit barcodes to confirm dispensation transactions, and several new enhancements to the Quantum Interactive™ agile design platform.
Cenduit’s Director of Product Management Kim Lanza-Russo explained, “In today’s increasingly complex clinical research environment, sites rely on Cenduit to deliver an innovative, agile approach in Randomization and Trial Supply Management [RTSM] to meet patient outcomes. As always, with this new release, we asked users about their challenges, and continue to create quality enhancements that improve scalability and deliver quantifiable value in the study build process.”
Quantum Interactive™ enhancements included in this release further enable the ability to support customizations that are critical for meeting the needs of complex studies. The enhancements include:
- Capturing customization as part of the study specifications within Quantum Interactive™; this includes re-supply customization; report customization; data transfer; and tasks and alerts.
- Incorporating the creation of study reports within the initial study build phase; ensuring reports are made instantly available.
A technology-based innovation unlike any other in the market, Quantum Interactive™ creates a high-quality functioning prototype of the initial study build. The platform provides a user-friendly interface to guide the study build process for faster requirements discovery and is highly configurable, meeting the needs of any study design.
Kim Lanza-Russo added, “Cenduit continues its commitment to innovation, with an enterprise perspective based on years of experience, built with quality in mind. We continue increasing the scalability and power of our platform to meet and anticipate our users’ needs, no matter how complex.”
About Cenduit LLC
Cenduit enables clinical trial sponsors and CROs to safely, quickly and economically deliver new drugs and therapies to help save and improve lives. As the world leader in IRT systems, Cenduit offers customers consistently innovated rapid study startup software, clinical supply chain intelligence, clinical operations expertise and customer-centric CORE teams. With 500+ experts throughout the US, Europe and Asia, Cenduit helps customers manage clinical trials in over 100 countries, interacting with more than 600,000 patients at over 32,000 sites. Learn how Cenduit's experts can ensure your study needs are met on time and within budget. Visit www.cenduit.com for more information.
Contact:
Shannon L. Davies, Shannon.lappindavies@cenduit.com, +1 919-998-3393
Brenda Nashawaty, brenda@nashawaty.com, +1 617-688-3253